Evidence map›Paper›PMID 28416656›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Effect of cholesterol on the molecular structure and transitions in a clinical-grade lung surfactant extract.

Jenny Marie Andersson, Carl Grey, Marcus Larsson, Tiago Mendes Ferreira, Emma Sparr

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of high cholesterol in age-related COVID19 lethality.bioRxiv : the preprint server for biology · 2021
    Article
  11. Article
  12. The Potential Role of Bioactive Plasmalogens in Lung Surfactant.Frontiers in cell and developmental biology · 2021
    Review
  13. Article
  14. Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in anJournal of aerosol medicine and pulmonary drug delivery · 2020
    Article
  15. Structural Changes in Films of Pulmonary Surfactant Induced by Surfactant Vesicles.Langmuir : the ACS journal of surfaces and colloids · 2020
    Article
  16. Membrane Heterogeneity Beyond the Plasma Membrane.Frontiers in cell and developmental biology · 2020
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jenny Marie AnderssonPhysical Chemistry, Lund University, 221 00 Lund, Sweden.
Carl GreyDivision of Biotechnology, Lund University, 221 00 Lund, Sweden.
Marcus LarssonClinical Sciences, Department of Pediatrics, Lund University, S-22185 Lund, Sweden.
Tiago Mendes FerreiraNMR Group, Institut für Physik, Martin-Luther-Universität Halle-Wittenberg, 06108 Halle, Germany tiago.ferreira@physik.uni-halle.de emma.sparr@fkem1.lu.se.
Emma SparrPhysical Chemistry, Lund University, 221 00 Lund, Sweden; tiago.ferreira@physik.uni-halle.de emma.sparr@fkem1.lu.se.
Lund University · SEMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lipid-protein film covering the interface of the lung alveolar in mammals is vital for proper lung function and its deficiency is related to a range of diseases. Here we present a molecular-level characterization of a clinical-grade porcine lung surfactant extract using a multitechnique approach consisting of [Formula: see text]-[Formula: see text] solid-state nuclear magnetic spectroscopy, small- and wide-angle X-ray scattering, and mass spectrometry. The detailed characterization presented for reconstituted membranes of a lung extract demonstrates that the molecular structure of lung surfactant strongly depends on the concentration of cholesterol. If cholesterol makes up about 11% of the total dry weight of lung surfactant, the surfactant extract adopts a single liquid-ordered lamellar phase, [Formula: see text], at physiological temperatures. This [Formula: see text] phase gradually changes into a liquid-disordered lamellar phase, [Formula: see text], when the temperature is increased by a few degrees. In the absence of cholesterol the system segregates into one lamellar gel phase and one [Formula: see text] phase. Remarkably, it was possible to measure a large set of order parameter magnitudes [Formula: see text] from the liquid-disordered and -ordered lamellar phases and assign them to specific C-H bonds of the phospholipids in the biological extract with no use of isotopic labeling. These findings with molecular details on lung surfactant mixtures together with the presented NMR methodology may guide further development of pulmonary surfactant pharmaceuticals that better mimic the physiological self-assembly compositions for treatment of pathological states such as respiratory distress syndrome.

Indexed as

AnimalsCholesterolComplex MixturesLungProtein DomainsPulmonary SurfactantsSwineX-Ray DiffractionCholesterolComplex MixturesPulmonary Surfactantscholesteroldipolar recouplinglung surfactantorder parametersolid-state NMR

Identifiers

PMID28416656
PMCPMC5422789
OpenAlexW2606773284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.